Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case

Wed, August 5, 2026 at 2:03 PM UTC

0

STOCKHOLM, Aug 5 (Reuters) - Danish drugmaker Novo Nordisk said on Wednesday it had won a preliminary injunction against Ceban Ziekenhuisfarmacie B.V. from a district court in the Netherlands in a patent infringement case involving a compounded semaglutide nasal spray.

Advertisement

(Reporting by Anna Ringstrom, editing by Elviira Luoma)

Original Article on Source

Source: “AOL Money”